23andMe GATTACA children Patents, Google Master Race

(Sergey and Anne, divorced now)I have not posted in forever. Before I used to post on novel efforts for Personalized Medicine I thought would be promising. Some of those are coming closer, like CardioDX or HCV genotypic treatment.I also would post on things I thought would stall and distract us. One of the biggest culprits to this in my humble opinion was the model of Direct to Consumer testing that offered medical test results. Why did I opine on this? Why was I so concerned? In 2007 I stared at Linda Avey and I saw the total lack of concern to duty for the noble calling. I also saw a lack of concern for patient lives. 23andMe repeatedly have incorrect testing results, their desire to use a database for genomic patents, their desire to end around research ethics by first doing research without an IRB. This information prompted me to write a scathing warning in Nature Biotechnology in May of 2009. "In need of a reality Check" serves as a reminder that mega-lord Tech companies are dedicated to profit, not to the hippocratic oath. Not that I begrudge them for that. I just feel my country should contemplate what a company should be doing in the human care and healthcare space.When asked what is the duty of a DTC company to offer follow up or change of a variant of uncertain significance or interpretation. Joanna Mountain looked at Linda Avey, Linda nodded and Joanna said "We don't have a duty to follow up!"I was incredulous and countered this assertion. I said, as a physici...
Source: Gene Sherpas: Personalized Medicine and You - Category: Geneticists and Genetics Commentators Source Type: blogs